Press Releases
Wed Sep 4, 2024 07:30 am
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
Tue Aug 20, 2024 07:30 am
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
Mon Aug 12, 2024 08:30 am
Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman
Tue Jul 2, 2024 08:30 am
Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes
Mon Jun 17, 2024 04:10 pm
Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel
Thu May 30, 2024 08:30 am
Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1
Tue Apr 16, 2024 08:30 am
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.
Fri Mar 29, 2024 04:44 pm
UPDATE - Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines
Tue Mar 26, 2024 08:30 am